Surmodics amends bylaws to tighten shareholder nomination and proxy rules

SURMODICS INC

New notice requirements for shareholder director nominees, including background info on nominee and nominating shareholder.
Company may void nominations if proxy notice under Rule 14a-19 is withdrawn, non-compliant, or unsupported by reasonable evidence.
Directors can now submit advance written consent or opposition to proposals even if absent from the meeting.
Regular board meetings date/time/place can be set by announcement at prior meeting.
Non-company proxy solicitations must use proxy cards of a color other than white; meeting conduct rules expanded.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

SURMODICS INC: Amended and restated Bylaws to update director nomination procedures, proxy solicitation rules, board meeting procedures, and shareholder meeting conduct (effective 2023-07-20).

Change: bylaw amendment
Effective: 2023-07-20

Exact text from the filing

On July 20, 2023, the Board of Directors of Surmodics, Inc. (the “Company”) adopted certain amendments, effective upon adoption, and restated the Bylaws of the Company (as amended, the “Restated Bylaws”).

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0000950170-23-034562

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.